Dynamics of COX-2 in nasal mucosa and nasal polyps from aspirin-tolerant and aspirin-intolerant patients with asthma
about
Initial surgical treatment for chronic frontal sinusitis: a pilot studyLipoxin A4 levels in asthma: relation with disease severity and aspirin sensitivityHypersensitivity to Aspirin and other NSAIDs: Diagnostic Approach in Patients with Chronic Rhinosinusitis.Signal transduction pathways (MAPKs, NF-κB, and C/EBP) regulating COX-2 expression in nasal fibroblasts from asthma patients with aspirin intolerance.Upregulation of COX-1 and COX-2 in nasal polyps in cystic fibrosisTissue remodelling in upper airways: where is the link with lower airway remodelling?Significance of susceptible gene expression profiles in nasal polyposisActivity of the cyclooxygenase 2-prostaglandin-E prostanoid receptor pathway in mice exposed to house dust mite aeroallergens, and impact of exogenous prostaglandin E2.Release of cyclooxygenase-2 and lipoxin A4 from blood leukocytes in aspirin-exacerbated respiratory diseaseAspirin desensitization: useful treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in aspirin-exacerbated respiratory disease (AERD)?Antileukotrienes in rhinosinusitis and nasal polyposis.Expression of arachidonate metabolism enzymes and receptors in nasal polyps of aspirin-hypersensitive asthmatics.Low prostaglandin E2 and cyclooxygenase expression in nasal mucosa fibroblasts of aspirin-intolerant asthmatics.Relationship between Toll-like receptor-4 and mPGES-1 gene expression in local lesions of endometriosis patients.Non-steroidal anti-inflammatory drugs-induced urticaria and angioedema: more research on mechanisms needed.Relevance of COX-2 gene expression in dementia with lewy bodies associated with Alzheimer pathology.Role of prostaglandin D2 and E2 terminal synthases in chronic rhinosinusitis.
P2860
Q28210147-AA4B604E-AEA0-4CC1-85D8-E571A5D74EF2Q28221900-BE4247BA-0AB2-4A1D-AB5D-781DBBD15ED1Q30407185-3F664613-168E-4258-ABEA-EE97B6ECEDB0Q30459926-771250DF-B309-4ACC-B76E-6BB7E0FB21F2Q36184104-A59AA46A-9563-4A09-8446-7D9D5CDF97D4Q36604438-03629FAA-03A2-4C29-B9A6-B18CEA679A06Q37165556-8D7F79EB-E38B-42D8-90AC-D2FF29398145Q37418337-6C587A8E-05F0-42D7-9950-BA67F065655EQ42266554-73FD98ED-1AD0-440C-B894-5A85CFECAFAAQ42456593-1C511215-FF5D-4BB1-947F-B2F4376537D6Q43061713-F10476C1-51A0-4E0A-8CDB-0CA3908CC32CQ46034358-625BD781-68EE-453C-91B0-2B4D56E5FB68Q46240727-E853EC87-079D-4C12-AF65-A46CFF6DB37FQ46254401-586FBC93-AABB-48C3-92AF-5609A21FF1DDQ46559672-8E498F42-04BB-4D49-A1A4-611D87D5AD07Q53391751-0F6D1C42-4346-4152-BA7C-4F547A35273CQ54587415-8047C378-1544-47E6-8011-ABF384FB1BE2
P2860
Dynamics of COX-2 in nasal mucosa and nasal polyps from aspirin-tolerant and aspirin-intolerant patients with asthma
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Dynamics of COX-2 in nasal muc ...... ntolerant patients with asthma
@ast
Dynamics of COX-2 in nasal muc ...... ntolerant patients with asthma
@en
Dynamics of COX-2 in nasal muc ...... ntolerant patients with asthma
@nl
type
label
Dynamics of COX-2 in nasal muc ...... ntolerant patients with asthma
@ast
Dynamics of COX-2 in nasal muc ...... ntolerant patients with asthma
@en
Dynamics of COX-2 in nasal muc ...... ntolerant patients with asthma
@nl
prefLabel
Dynamics of COX-2 in nasal muc ...... ntolerant patients with asthma
@ast
Dynamics of COX-2 in nasal muc ...... ntolerant patients with asthma
@en
Dynamics of COX-2 in nasal muc ...... ntolerant patients with asthma
@nl
P2093
P1476
Dynamics of COX-2 in nasal muc ...... ntolerant patients with asthma
@en
P2093
Antoni Xaubet
César Picado
Isam Alobid
Joaquim Mullol
P356
10.1016/J.JACI.2004.07.050
P407
P577
2004-10-01T00:00:00Z